FindTrial
Sign In

Establishment and clinical application of AI-based multimodal diagnosis system for ovarian tumors

Establishment and clinical application of AI-based multimodal diagnosis system for ovarian tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093381
Enrollment
Unknown
Registered
2024-12-03
Start date
2025-01-01
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian tumors

Interventions

Gold Standard:Pathological diagnosis
Index test:The AI-based multimodal ovarian tumor diagnostic support system

Sponsors

Beijing Shijitan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Continuous cases admitted for diagnosis of ovarian tumor and preparation for surgical treatment; 2. Complete imaging data (ultrasound or MRI) and tumor marker results within 3 months before surgery; 3. Voluntarily sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with non-ovarian origin tumor as surgical pathology; 2. Repetitive cases; 3. Cases receiving radiotherapy and chemotherapy; 4. Recurrent cases; 5. Poor image quality of ovarian lesions; 6. Incomplete case information.

Design outcomes

Primary

MeasureTime frame
Ultrasound images;Magnetic resonance imaging (MRI) images;Pathological diagnosis;Accuracy;Sensitivity;Specificity;—

Countries

China

Contacts

Public ContactWenpei Bai

Beijing Shijitan Hospital, Capital Medical University

baiwp@bjsjth.cn+86 133 6615 7805

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026